Getting ready for MACRA

Providing meaningful real-world evidence (RWE) to providers—to enable them to better manage healthcare services—will be a growing part of the life sciences industry’s marketing activity in coming years, according to stakeholders convened by the Network for Excellence in Health Innovation, […]

Read More

A Conversation with John Chiminski, Catalent

In April, Catalent, Inc., celebrated its 10th anniversary of its inception, having been spun out of Cardinal Health in 2007 and acquired by Blackstone Group, a private-equity firm. Later, in 2014, the company went public, traded on the NYSE. Both […]

Read More

INC Research and Inventiv Health to merge

The No. 7 (by revenue) contract research organization, INC Research, and the No. 6 CRO, inVentiv Health, are merging, creating what the company managements expect will be the No. 3 CRO, plus, by virtue of inVentiv’s “contract commercial organization,” a […]

Read More

Health plan managers seek more information on drug utilization

EMD Serono’s Specialty Digest polls health plan managers (this year: 58 plans representing 173 million lives) on their challenges, accomplishments and opportunities in managing the use of specialty drugs among their ensured lives. Besides growing dramatically (specialty products now represent […]

Read More